Skip to main content

Table 2 Cross-sectional associations of serum cystatin C and impaired kidney function with prevalent geriatric depressive symptoms (n = 1440)

From: Serum cystatin C, impaired kidney function, and geriatric depressive symptoms among older people living in a rural area: a population-based study

Serum cystatin C or impaired kidney function

N/n

Odds ratio (95% confidence interval)

Model 1a

Model 2a

Model 3a

Cystatin C, mg/L

 ≤ 1.00

768/119

1.00 (reference)

1.00 (reference)

1.00 (reference)

 1.01–1.25

360/79

1.43 (1.03–1.98)

1.40 (1.004–1.95)

1.41 (1.009–1.97)

 > 1.25

312/118

3.25 (2.39–4.42)

3.30 (2.40–4.50)

3.20 (2.32–4.41)

 P for trend

 

< 0.001

< 0.001

< 0.001

Impaired kidney function

 No

1070/176

1.00 (reference)

1.00 (reference)

1.00 (reference)

 Yes

370/140

3.07 (2.34–4.03)

3.03 (2.30–4.01)

2.95 (2.22–3.92)

  1. N/n indicates number of subjects/number of persons with depressive symptoms
  2. Abbreviations: MMSE mini-mental state examination, ADL activities of daily living
  3. aModel 1 was adjusted for age, sex, and education; model 2 was additionally adjusted for alcohol consumption, hypertension, stroke, heart disease, cataract, chronic obstructive pulmonary disease, nephritis, and arthritis; and in model 3, MMSE score and ADL-disability were added to model 2